Analgesic method containing Lysine 2-(2-methyl-3-chloro-anilino)

Details Analgesic method containing Lysine 2-(2-methyl-3-chloro-anilino) Analgesic method containing Lysine 2-(2-methyl-3-chloro-anilino)

1974-10-15

1976-08-03

Ore, Dale R.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Parasitic organism or component thereof or substance...

424 14, A61K 31455

Patent

active

039730271

ABSTRACT:
Novel analgesic pharmaceutical compositions are disclosed, wherein the active principle is Lysine 2-(2-methyl-3-chloro-anilino)-3-nicotinate. The recommended dosage unit is from 10 to 500 milligrams of the active ingredient. The analgesic activity of the compound according to the invention is more than 20 times more intense than that of acetylsalicylic acid, taken as the unitary reference.

REFERENCES:
patent: 3172812 (1965-03-01), Halpern

Affiliated with

Also associated with

Rating

Analgesic method containing Lysine 2-(2-methyl-3-chloro-anilino) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Analgesic method containing Lysine 2-(2-methyl-3-chloro-anilino), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Analgesic method containing Lysine 2-(2-methyl-3-chloro-anilino) will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1930233